PanOptix® Trifocal IOL

With several prospective clinical studies now complete, and the number of surgeons with experience of the platform increasing, the evidence base for Alcon's PanOptix^® Trifocal IOL has grown considerably. In this clinical update, you can find an overview of recently published and presented PanOptix® safety and efficacy data from experienced surgeons, as well as a comparison with other IOL options available on the market.

^{© 2020 Alcon Inc. 06/20 US-ACP-2000166}